IN BRIEF: Aptamer raises GBP2 million for Optimer commercialisation
4th Jul 2025 11:36
Aptamer Group PLC - York, England-based biotechnology firm that provides Optimer binders for use in therapeutics, diagnostics, bioprocessing and research - Raises GBP2.0 million from placing of 666.7 million new shares at 0.3 pence. Part of the equity raise is conditional on shareholder approval at a general meeting called for July 24. Chair Adam Hargreaves invests GBP100,000 in the equity raise, putting his stake at 6.4%. Aptamer says it will use the fresh funds to "accelerate the commercialisation of its Optimer technology, further develop its intellectual property portfolio, and advance its licensing pipeline." Read More